Literature DB >> 18370087

Freezing harvested hMSCs and recovery of hMSCs from frozen vials for subsequent expansion, analysis, and experimentation.

Roxanne L Reger1, Margaret R Wolfe.   

Abstract

Human multipotential stromal cells (hMSCs) are easily isolated from bone marrow and can be expanded by up to 200-fold in culture. Cultures of hMSCs are heterogeneous mixtures of stem/progenitor cells and more mature cell types. The proportion of each cell type in a given culture depends on how the cells are maintained. To maintain their stem cell-like qualities, hMSCs should be plated at low seeding densities (60-150 cells/cm2), lifted when between 60% and 80% confluent and should not be expanded beyond 4-5 passages. Thus, it is useful to establish a frozen bank of early passage cells. hMSCs store well in vapor phase liquid nitrogen (LN2) and are easily recovered for further expansion. This chapter describes one method of establishing a bank of early passage hMSCs using a seed lot system and the subsequent recovery of hMSCs from frozen stocks. The recovered cells can then be harvested and used for analyses of identification, functionality, in vitro and/or in vivo experimentation, or further expanded.

Entities:  

Mesh:

Year:  2008        PMID: 18370087     DOI: 10.1007/978-1-60327-169-1_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells?

Authors:  Roxanne L Reger; Darwin J Prockop
Journal:  Stem Cells Transl Med       Date:  2014-04-01       Impact factor: 6.940

2.  Nanotopography as modulator of human mesenchymal stem cell function.

Authors:  Karina Kulangara; Yong Yang; Jennifer Yang; Kam W Leong
Journal:  Biomaterials       Date:  2012-04-18       Impact factor: 12.479

3.  ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells.

Authors:  Sarah A Maas; Nina M Donghia; Kathleen Tompkins; Oded Foreman; Kevin D Mills
Journal:  BMC Biol       Date:  2010-10-27       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.